Source: Annual Congress 2001 - Rare and unusual diseases or problems
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. G. Koroleva, L. N. Novikova, O. P. Baranova, M. M. Ilkovich (Saint-Petersburg, Russia). Familial case of cryptogenic fibrosing alveolitis in two siblings. Eur Respir J 2001; 16: Suppl. 31, 1524

Member's Comments

No comment yet.

Related content which might interest you: The features of the course of cryptogenic fibrosing alveolitis in women Source: Eur Respir J 2002; 20: Suppl. 38, 59s Year: 2002 Specific features of the course of cryptogenic fibrosing alveolitis in pregnancy Source: Eur Respir J 2001; 18: Suppl. 33, 150s Year: 2001 Lung cancer in patients with cryptogenic fibrosing alveolitis Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 18: 43S-55S Year: 2001 Sputum eosinophilia in cryptogenic fibrosing alveolitis Source: Eur Respir J 2003; 22: Suppl. 45, 227s Year: 2003 Analysis of IL-13 polymorphisms in patients with cryptogenic fibrosing alveolitis Source: Eur Respir J 2001; 18: Suppl. 33, 411s Year: 2001 Hemocoagulation and platelet aggregation disorders in patients with cryptogenic fibrosing alveolitis (CFA) Source: Eur Respir J 2002; 20: Suppl. 38, 226s Year: 2002 Parameters of antioxidant protection in patients with cryptogenic fibrosing alveolitis Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation Year: 2007 Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature Source: Eur Respir Rev 2012 21: 355-361 Year: 2012 Hemostasis disorders and their correction using ticlopidine in patients with cryptogenic fibrosing alveolitis (CFA) Source: Eur Respir J 2003; 22: Suppl. 45, 84s Year: 2003 Coexistence of pulmonary sarcoidosis and polymyositis with organising pneumonia - a case report Source: Eur Respir J 2005; 26: Suppl. 49, 81s Year: 2005 BOOP as presenting manifestation of idiopathic hyper-eosinophilic syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 375s Year: 2005 Pulmonary fibrosis: “idiopathic” is not “cryptogenic” Source: Eur Respir J, 53 (3) 1802314; 10.1183/13993003.02314-2018 Year: 2019 Pulmonary fibrosis: “idiopathic” is not “cryptogenic” Source: Eur Respir J, 53 (3) 1900400; 10.1183/13993003.00400-2019 Year: 2019 Occupational dust exposure and the aetiology of cryptogenic fibrosing alveolitis Source: Eur Respir J 2001; 18: 119S-121S Year: 2001 Cytokine regulation in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis: clinicomorphological study Source: Eur Respir J 2001; 18: Suppl. 33, 107s Year: 2001 15-year follow-up of patients with cryptogenic fibrosing alveolitis (CFA) Source: Eur Respir J 2002; 20: Suppl. 38, 455s Year: 2002 A rare case of idiopathic pulmonary fibrosis in children Source: Eur Respir J 2007; 30: Suppl. 51, 390s Year: 2007 Clinical significance of morphological indexes of inflammation and sclerosis in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 107s Year: 2002 The study of C5a complement component in patients with idiopathic pulmonary fibrosis, toxic fibrosing alveolitis and extrinsic allergic alveolitis Source: Eur Respir J 2001; 18: Suppl. 33, 108s Year: 2001